Viimed teams up with JHHC to enhance digital healthcare

Washington-based digital health company, Viimed has signed a five-year contract with Johns Hopkins HealthCare LLC (JHHC), a division of Johns Hopkins Medicine to convert their evidenced-based health solutions to digital form and offer them to hospitals and patients.

The focus of the two initial Johns Hopkins programs is on changing behavior of individuals with either pre-diabetes or type 2 diabetes.

The DECIDE program helps people with diabetes learn to change their behavior so they can better self-manage. This unique interactive program improves both self-management skills and diabetes health outcomes.

DECIDE has shown positive outcomes in studies of high risk, low-literacy populations. In addition, the program has been shown to improve A1C levels, blood pressure and cholesterol.

ACT2 is an interactive, year-long support and engagement program that is designed to empower those at high-risk of diabetes to take charge of their own health and well-being.

In 2018, the Centers for Medicare & Medicaid Services is scheduled to announce performance-based reimbursement for diabetes prevention, and ACT2 will seamlessly enable organizations to implement this program into their workflow.